ABSTRACT
Mitochondrial dysfunction is an early and prominent feature of Alzheimer’s disease (AD), with impaired energy metabolism preceding the onset of clinical symptoms. Here we propose an update to the mitochondrial dysfunction hypothesis of AD based on recent results examining the role of mitochondrial genome abundance in AD. In a large post-mortem study, we show that lower brain mitochondrial genome abundance is associated with a greater odds of AD neuropathological change and worse cognitive performance. We hypothesize that lower mitochondrial genome abundance impairs mitochondrial function by reducing mitochondrial bioenergetics, thereby impacting neuronal and glial cell function. However, it remains to be determined if mitochondrial dysfunction causes, mediates, or is a by-product of AD pathogenesis. Additional support for this hypothesis will be generated by linking peripheral blood mitochondrial genome abundance to AD and establishing clinical trials of compounds that upregulate total mitochondrial genome abundance or boost mitochondrial mass.
Systematic Review The authors used PubMed to review the literature on mitochondrial genomics in Alzheimer’s disease (AD) using the following search term: mitochondria* AND (“copy number” OR heteroplasmy OR haplogroup*) AND “Alzheimer’s disease”. The accumulated evidence suggested that increased mitochondrial genome abundance is neuroprotective, but found conflicting evidence for the association of mitochondrial heteroplasmy or specific haplogroups with AD.
Interpretation We found that higher mtDNA abundance was robustly associated with reduced AD neuropathology burden and higher neurocognitive performance. Given these findings, we propose an updated hypothesis for mitochondrial dysfunction in AD: that mitochondrial genome abundance is a relevant mechanism in AD pathogenesis. We postulate that baseline mtDNA abundance itself contributes to baseline mitochondrial function and lifetime risk, and that propensity and sensitivity to mtDNA depletion further modulate risk, histopathology, and clinical decline.
Future directions Using statistical genetics approaches, examining the association of peripheral mtDNA abundance with AD, and upregulating mtDNA abundance, would further strengthen the evidence of a causal role for mtDNA abundance and mitochondrial dysfunction in AD pathogenesis
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Alzheimer's Association
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Mount Sinai determined that the proposed activity "Assessing the causal role of mitochondria in Alzheimer's disease (GCO# 19-2576)" is not human research as defined by DHHS and FDA regulations
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
